L
Lindsay R. Berry
Researcher at University of Pittsburgh
Publications - 26
Citations - 1421
Lindsay R. Berry is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 6, co-authored 16 publications receiving 484 citations. Previous affiliations of Lindsay R. Berry include Duke University.
Papers
More filters
Journal ArticleDOI
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Derek C. Angus,Lennie P. G. Derde,Farah Al-Beidh,Djillali Annane,Yaseen M. Arabi,Abi Beane,Wilma van Bentum-Puijk,Lindsay R. Berry,Zahra Bhimani,Marc J. M. Bonten,Charlotte Bradbury,Frank M. Brunkhorst,Meredith Buxton,Adrian Buzgau,Allen C. Cheng,Menno de Jong,Michelle A. Detry,Lise J Estcourt,Lise J Estcourt,Mark Fitzgerald,Herman Goossens,Cameron Green,Rashan Haniffa,Alisa Higgins,Christopher M. Horvat,Sebastiaan J. Hullegie,Peter Kruger,Francois Lamontagne,Patrick R. Lawler,Kelsey Linstrum,Edward Litton,Elizabeth Lorenzi,John E. A. Marshall,John E. A. Marshall,Daniel F. McAuley,Anna McGlothin,Shay McGuinness,Shay McGuinness,Shay McGuinness,Bryan J. McVerry,Stephanie K. Montgomery,Paul R Mouncey,Srinivas Murthy,Alistair Nichol,Rachael Parke,Rachael Parke,Rachael Parke,Jane Parker,Kathryn M Rowan,Ashish Sanil,Marlene Santos,Christina Saunders,Christopher W. Seymour,Anne Turner,Frank L. van de Veerdonk,Balasubramanian Venkatesh,Balasubramanian Venkatesh,Ryan Zarychanski,Scott M. Berry,Roger J. Lewis,Roger J. Lewis,Colin McArthur,Steven A R Webb,Steven A R Webb,Steven A R Webb,Anthony C. Gordon +65 more
TL;DR: To determine whether hydrocortisone improves outcome for patients with severe COVID-19, an ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin was conducted.
Journal ArticleDOI
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
Manu Shankar-Hari,Claire L Vale,Peter J. Godolphin,David Fisher,Higgins Jpt.,Francesca Spiga,Jelena Savović,Jelena Savović,Jayne F. Tierney,Gabriel Baron,Julie Benbenishty,Lindsay R. Berry,N Broman,Alexandre Biasi Cavalcanti,R Colman,S. De Buyser,Derde Lpg.,P Domingo,S F Omar,A Fernandez-Cruz,T Feuth,F Garcia,R Garcia-Vicuna,I Gonzalez-Alvaro,Anthony C. Gordon,Richard Haynes,Olivier Hermine,Peter Horby,Nora Horick,K Kumar,B N Lambrecht,Martin J Landray,L Leal,D J Lederer,Elizabeth Lorenzi,X Mariette,N Merchante,N A Misnan,S V Mohan,M C Nivens,J Oksi,J A Perez-Molina,R Pizov,R Porcher,S Postma,R Rajasuriar,Athimalaipet V Ramanan,P Ravaud,Pankti Reid,Abraham Rutgers,A Sancho-Lopez,Todd B. Seto,S Sivapalasingam,A S Soin,Natalie Staplin,John H. Stone,Garth W. Strohbehn,J Sunden-Cullberg,J Torre-Cisneros,L W Tsai,H. van Hoogstraten,T. van Meerten,Viviane C Veiga,P E Westerweel,Srinivas Murthy,Janet V. Diaz,John C. Marshall,Sterne Jac. +67 more
TL;DR: In this article, a prospective meta-analysis of clinical trials of patients hospitalized for COVID-19, administration of IL-6 antagonists, compared with usual care or placebo, was associated with lower 28-day all-cause mortality.
Journal ArticleDOI
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Charlotte Bradbury,Patrick R. Lawler,Simon J. Stanworth,Bryan J. McVerry,Zoe McQuilten,Alisa Higgins,Paul R Mouncey,Farah Al-Beidh,Kathryn M Rowan,Lindsay R. Berry,Elizabeth Lorenzi,Ryan Zarychanski,Yaseen M. Arabi,Djillali Annane,Abi Beane,Wilma van Bentum-Puijk,Zahra Bhimani,Shailesh Bihari,Marc J. M. Bonten,Frank M. Brunkhorst,Adrian Buzgau,Meredith Buxton,Marc Carrier,Allen C. Cheng,Matthew E. Cove,Michelle A. Detry,Lise J Estcourt,Mark Fitzgerald,Timothy D. Girard,Ewan C. Goligher,Herman Goossens,Rashan Haniffa,Thomas Hills,David T. Huang,Christopher M. Horvat,Beverley Hunt,Nao Ichihara,Francois Lamontagne,Helen L. Leavis,Kelsey Linstrum,Edward Litton,John C. Marshall,Daniel F. McAuley,Anna McGlothlin,Shay McGuinness,Saskia Middeldorp,Stephanie K. Montgomery,Susan C. Morpeth,Srinivas Murthy,Matthew D. Neal,Alistair Nichol,Rachael Parke,Jane Parker,Luis Reyes,Hiroki Saito,Marlene Santos,Christina Saunders,Ary Serpa-Neto,Christopher W. Seymour,Manu Shankar-Hari,Vanessa Singh,Timo Tolppa,Alexis F. Turgeon,Anne Turner,Frank L. van de Veerdonk,Cameron M. Green,Roger J. Lewis,Derek C. Angus,Colin McArthur,Scott M. Berry,Lennie P. G. Derde,Steve Webb,Anthony C. Gordon +72 more
TL;DR: Among critically ill patients with COVID-19, treatment with an antiplatelet agent, compared with no antiplatelets, had a low likelihood of providing improvement in the number of organ support-free days within 21 days, and was statistically pooled for further analysis.
Journal ArticleDOI
Bayesian Forecasting of Many Count-Valued Time Series
Lindsay R. Berry,Mike West +1 more
TL;DR: A novel multiscale approach—one new example of the concept of decouple/recouple in time series—enables information sharing across series, and hence enables scalability in the number of series.
Journal ArticleDOI
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Yaseen M. Arabi,Yaseen M. Arabi,Anthony C. Gordon,Anthony C. Gordon,Lennie P. G. Derde,Alistair Nichol,Alistair Nichol,Alistair Nichol,Srinivas Murthy,Farah Al Beidh,Djillali Annane,Lolowa Al Swaidan,Lolowa Al Swaidan,Abi Beane,Richard Beasley,Lindsay R. Berry,Zahra Bhimani,Marc J. M. Bonten,Charlotte Bradbury,Charlotte Bradbury,Frank M. Brunkhorst,Meredith Buxton,Adrian Buzgau,Allen C. Cheng,Menno de Jong,Michelle A. Detry,Eamon Duffy,Lise J Estcourt,Lise J Estcourt,Mark Fitzgerald,Rob Fowler,Rob Fowler,Timothy D. Girard,Ewan C. Goligher,Herman Goossens,Rashan Haniffa,Rashan Haniffa,Alisa Higgins,Thomas Hills,Christopher M. Horvat,Christopher M. Horvat,David T. Huang,Andrew J King,Francois Lamontagne,Patrick R. Lawler,Patrick R. Lawler,Roger J. Lewis,Kelsey Linstrum,Edward Litton,Edward Litton,Edward Litton,Elizabeth Lorenzi,Salim Malakouti,Daniel F. McAuley,Anna McGlothlin,Shay McGuinness,Shay McGuinness,Shay McGuinness,Bryan J. McVerry,Stephanie K. Montgomery,Susan C. Morpeth,Paul R Mouncey,Katrina Orr,Rachael Parke,Rachael Parke,Rachael Parke,Jane C. Parker,Asad E. Patanwala,Asad E. Patanwala,Kathryn M Rowan,Marlene Santos,Christina Saunders,Christopher W. Seymour,Manu Shankar-Hari,Manu Shankar-Hari,Steven Y. C. Tong,Steven Y. C. Tong,Alexis F. Turgeon,Anne Turner,Frank L. van de Veerdonk,Ryan Zarychanski,Cameron Green,Scott M. Berry,John C. Marshall,John C. Marshall,Colin McArthur,Derek C. Angus,Steven A R Webb,Steven A R Webb +88 more
TL;DR: In this article, the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19) was studied.